• Ernie Shin, Founder & CEO

  PProven leader with experience launching and scaling ventures to operational success, including advising several public and private companies

  Founding team member and COO, VGX Pharmaceuticals (merged with Inovio, Nasdaq: INO)

  Served as Global Planner/Manager at Roche, overseeing strategic supply operations

  Worked as Aerospace Project Engineer, US Naval Air Systems Command, Department of Defense

  NJ State Certified Volunteer Firefighter

  BS in Mechanical/Aerospace Eng., Rutgers Eng.

  MBA in Finance & Entrepreneurial Mgt., Wharton

• Bill Krolicki,CBO and CFO

  25+ years as CFO across global corporations

  Evaluated, negotiated, and closed complex deals, including cross-border M&A and public listings

  Led financial reporting, restructuring, budgeting, and cash flow forecasting

  Executed IPOs, due diligence, and cross-border deals

  Former CFO, International Packaging Corporation and Origins Holdings AG; led Nasdaq listing and financial oversight at SGOCO

  B.A., Middlebury College; MBA/MA in International Studies and Finance, The Lauder Institute - Wharton School

• Thomas Bordner, Chief IP Officer and General Counsel

  Senior Director Intellectual Property and Corporate Attorney, Vesigen Therapeutics, Inc.

  Partner, Prince Lobel Tye, LLP

  Principal, BIPLaw, LLC

  Director of Intellectual Property, Sanofi Pasteur, Inc.

  National Association of Patent Practitioners

  American Intellectual Property Law Association

  Biotechnology, The Johns Hopkins University

  Juris Doctor, The University of Toledo College of Law

• Lynette Liu,Chief Operations Officer

  Marketing Manager, Facebook

  Project Manager, SurveyMonkey

  Marketing Consultant, Intuit

  Product Manager, GoDaddy (formerly Outright)

  Business Dev. and IT Project Manager, Oracle

  Product Manager, Sun Microsystems

  Hardware Design Engineer, Texas Instruments

  MBA, The Wharton School

  Master of Science (M.S.), Electrical Engineering, UCLA

  B.S., Electrical Eng., The Johns Hopkins University

Scientific & Medical Advisory Board

• Jinhwan Kim, Ph.D., Chief Science Advisor

  Assistant Professor, UC Davis

  NK cell cancer therapy: Nanotechnology & Imaging

  Research Scientist, Georgia Tech: Led nanoparticle-enhanced T-cell therapy and cancer imaging projects

  NIH K99/R00 Award (2022): Recognized for CAR T cell therapy innovations using nanoparticle technology

  Awards: SPIE Best Paper(23), UC Davis Pilot Research

  Advancing nanotechnology for cancer therapy, imaging, and clinical applications

  Ph.D., POSTECH: Biomimetic Nanomaterials

• Wook J. Chun, M.D.,Medical Advisor

  Internal Medicine Specialist, Optum/UnitedHealth Group

  Director, Medical Center and Rehabilitation Hospital

  Medical Director, Noble Hospice, Arizona

  B.S. Johns Hopkins University

  M.A. in Epidemiology and public health, Yale University

  M.D. School of Medicine, Wayne State University

Clinical Advisory Board

• Professor Si Young Song

  Professor Emeritus, Yonsei University College of Medicine

  Chairman, the Korean Society of Gastrointestinal Cancer Research

  Dean & Alumnus, Yonsei Univ. College of Medicine

  President, the Korean Pancreatobiliary Association

  A recipient of the National Medal for exceptional service

  M.D., Yonsei University College of Medicine

• Professor Ho Soon Choi

  Chief Medical Diretor, Gangnam Eulji Hospital (Current)

  Hanyang Univ. Medical Vice-Chancellor and Chief

  Director, Korean Society of Gastrointestinal Endoscopy

  Chairman, the Korean Pancreatobiliary Association

  President of the Korean Society of Internal Medicine

  Dean of Hanyang University College of Medicine

  M.D., Hanyang University